WIRED spoke with Boris Cherny, head of Claude Code, about how the viral coding tool is changing the way Anthropic works.

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

The first season of HBO's It: Welcome to Derry has come to a close, leaving us with a long list of questions that need to somehow be answered when the show leaps back in time another 27 years for ...

Warning: this article contains full spoilers for Andor Season 2’s finale. If you haven’t already, be sure to check out IGN's review for Andor Season 2, Episodes 10-12. Andor Season 2 just wrapped on ...

Wicked: For Good concludes the tale of doomed friendship between Elphaba (Cynthia Erivo) and Glinda (Ariana Grande), turning to a new page in the Grimmerie as the story ends. The film is an ...

Recursion Pharmaceuticals, Inc. leverages AI to accelerate drug discovery, offering both a licensing platform and an internal drug development pipeline. RXRX faces heavy competition, ongoing operating ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

SPOILER ALERT: This story contains spoilers for the first two episodes of “Pluribus,” streaming now on Apple TV. Not only did “Breaking Bad” earn four more seasons that cemented it as one of the ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...